<i>PD-1</i> gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hidefumi,Sasaki

第一单位： Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467-8601, Japan.

作者： Hidefumi,Sasaki ^[1] ; Tsutomu,Tatemaysu ^[1] ; Katsuhiro,Okuda ^[1] ; Satoru,Moriyama ^[1] ; Motoki,Yano ^[1] ; Yoshitaka,Fujii ^[1]

作者单位： Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467-8601, Japan. ^[1]

关键词 immunotherapy lung cancer prognosis programmed death 1 squamous cell carcinomas

DOI 10.3892/mco.2014.358

PMID 25279194

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览18

Molecular and clinical oncology

2014年2卷6期

1035-1042页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

<i>PD-1</i> gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

<i>PD-1</i> gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer.

Molecular and clinical oncology

相似文献

Molecular and clinical oncology

相关期刊

检索历史清除